Literature DB >> 25180240

Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study.

Steve M Taylor1, Christian M Parobek2, Derrick K DeConti3, Kassoum Kayentao4, Sheick Oumar Coulibaly5, Brian M Greenwood6, Harry Tagbor7, John Williams8, Kalifa Bojang9, Fanta Njie9, Meghna Desai10, Simon Kariuki11, Julie Gutman12, Don P Mathanga13, Andreas Mårtensson14, Billy Ngasala15, Melissa D Conrad16, Philip J Rosenthal16, Antoinette K Tshefu17, Ann M Moormann18, John M Vulule19, Ogobara K Doumbo20, Feiko O Ter Kuile21, Steven R Meshnick22, Jeffrey A Bailey23, Jonathan J Juliano24.   

Abstract

Plasmodium falciparum parasites that are resistant to artemisinins have been detected in Southeast Asia. Resistance is associated with several polymorphisms in the parasite's K13-propeller gene. The molecular epidemiology of these artemisinin resistance genotypes in African parasite populations is unknown. We developed an assay to quantify rare polymorphisms in parasite populations that uses a pooled deep-sequencing approach to score allele frequencies, validated it by evaluating mixtures of laboratory parasite strains, and then used it to screen P. falciparum parasites from >1100 African infections collected since 2002 from 14 sites across sub-Saharan Africa. We found no mutations in African parasite populations that are associated with artemisinin resistance in Southeast Asian parasites. However, we observed 15 coding mutations, including 12 novel mutations, and limited allele sharing between parasite populations, consistent with a large reservoir of naturally occurring K13-propeller variation. Although polymorphisms associated with artemisinin resistance in P. falciparum in Southeast Asia are not prevalent in sub-Saharan Africa, numerous K13-propeller coding polymorphisms circulate in Africa. Although their distributions do not support a widespread selective sweep for an artemisinin-resistant phenotype, the impact of these mutations on artemisinin susceptibility is unknown and will require further characterization. Rapid, scalable molecular surveillance offers a useful adjunct in tracking and containing artemisinin resistance.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  artemisinin resistance; drug resistance; falciparum malaria; molecular epidemiology

Mesh:

Substances:

Year:  2014        PMID: 25180240      PMCID: PMC4402372          DOI: 10.1093/infdis/jiu467

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

Review 1.  Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies.

Authors:  Lasse S Vestergaard; Pascal Ringwald
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

2.  Malaria: a molecular marker of artemisinin resistance.

Authors:  Nicholas J White
Journal:  Lancet       Date:  2014-04-26       Impact factor: 79.321

3.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Authors:  Frédéric Ariey; Benoit Witkowski; Chanaki Amaratunga; Johann Beghain; Anne-Claire Langlois; Nimol Khim; Saorin Kim; Valentine Duru; Christiane Bouchier; Laurence Ma; Pharath Lim; Rithea Leang; Socheat Duong; Sokunthea Sreng; Seila Suon; Char Meng Chuor; Denis Mey Bout; Sandie Ménard; William O Rogers; Blaise Genton; Thierry Fandeur; Olivo Miotto; Pascal Ringwald; Jacques Le Bras; Antoine Berry; Jean-Christophe Barale; Rick M Fairhurst; Françoise Benoit-Vical; Odile Mercereau-Puijalon; Didier Ménard
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

4.  Accuracy of estimated phylogenetic trees from molecular data. II. Gene frequency data.

Authors:  M Nei; F Tajima; Y Tateno
Journal:  J Mol Evol       Date:  1983       Impact factor: 2.395

5.  Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes.

Authors:  Steve M Taylor; Christian M Parobek; Nash Aragam; Billy E Ngasala; Andreas Mårtensson; Steven R Meshnick; Jonathan J Juliano
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

6.  Origin and evolution of sulfadoxine resistant Plasmodium falciparum.

Authors:  Sumiti Vinayak; Md Tauqeer Alam; Tonya Mixson-Hayden; Andrea M McCollum; Rithy Sem; Naman K Shah; Pharath Lim; Sinuon Muth; William O Rogers; Thierry Fandeur; John W Barnwell; Ananias A Escalante; Chansuda Wongsrichanalai; Frederick Ariey; Steven R Meshnick; Venkatachalam Udhayakumar
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

7.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.

Authors:  Aung Pyae Phyo; Standwell Nkhoma; Kasia Stepniewska; Elizabeth A Ashley; Shalini Nair; Rose McGready; Carit ler Moo; Salma Al-Saai; Arjen M Dondorp; Khin Maung Lwin; Pratap Singhasivanon; Nicholas P J Day; Nicholas J White; Tim J C Anderson; François Nosten
Journal:  Lancet       Date:  2012-04-05       Impact factor: 79.321

8.  Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.

Authors:  Anju Singh; Vikas Misra; Rajesh K Thimmulappa; Hannah Lee; Stephen Ames; Mohammad O Hoque; James G Herman; Stephen B Baylin; David Sidransky; Edward Gabrielson; Malcolm V Brock; Shyam Biswal
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

9.  Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.

Authors:  Richard M Gibson; Ashley M Meyer; Dane Winner; John Archer; Felix Feyertag; Ezequiel Ruiz-Mateos; Manuel Leal; David L Robertson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

10.  Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.

Authors:  Chanthap Lon; Jessica E Manning; Pattaraporn Vanachayangkul; Mary So; Darapiseth Sea; Youry Se; Panita Gosi; Charlotte Lanteri; Suwanna Chaorattanakawee; Sabaithip Sriwichai; Soklyda Chann; Worachet Kuntawunginn; Nillawan Buathong; Samon Nou; Douglas S Walsh; Stuart D Tyner; Jonathan J Juliano; Jessica Lin; Michele Spring; Delia Bethell; Jaranit Kaewkungwal; Douglas Tang; Char Meng Chuor; Prom Satharath; David Saunders
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more
  162 in total

Review 1.  Understanding artemisinin-resistant malaria: what a difference a year makes.

Authors:  Rick M Fairhurst
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

2.  Molecular Epidemiology of Malaria in Cameroon and Côte d'Ivoire. XXXI. Kelch 13 Propeller Sequences in Plasmodium falciparum Isolates before and after Implementation of Artemisinin-Based Combination Therapy.

Authors:  Joseph Allico Djaman; Dagnogo Olefongo; Aristide Berenger Ako; Jocelyne Roman; Vincent Foumane Ngane; Leonardo K Basco; Rachida Tahar
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.

Authors:  Nicole L Davis; Eric J Barnett; William C Miller; Anna Dow; Charles S Chasela; Michael G Hudgens; Dumbani Kayira; Gerald Tegha; Sascha R Ellington; Athena P Kourtis; Charles van der Horst; Denise J Jamieson; Jonathan J Juliano
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

4.  Artemisinin resistance-associated polymorphisms at the K13-propeller locus are absent in Plasmodium falciparum isolates from Haiti.

Authors:  Tamar E Carter; Alexis Boulter; Alexandre Existe; Jean R Romain; Jean Yves St Victor; Connie J Mulligan; Bernard A Okech
Journal:  Am J Trop Med Hyg       Date:  2015-02-02       Impact factor: 2.345

5.  Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan.

Authors:  Abdelrahim O Mohamed; Maazza Hussien; Amal Mohamed; Abdelmaroof Suliman; Nuha S Elkando; Hanadi Abdelbagi; Elfatih M Malik; Mohammed H Abdelraheem; Muzamil Mahdi Abdel Hamid
Journal:  Malar J       Date:  2020-02-18       Impact factor: 2.979

6.  Plasmodium falciparum Kelch Propeller Polymorphisms in Clinical Isolates from Ghana from 2007 to 2016.

Authors:  Sena A Matrevi; Philip Opoku-Agyeman; Neils B Quashie; Selassie Bruku; Benjamin Abuaku; Kwadwo A Koram; Anne Fox; Andrew Letizia; Nancy O Duah-Quashie
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

7.  A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.

Authors:  Fang Huang; Shannon Takala-Harrison; Christopher G Jacob; Hui Liu; Xiaodong Sun; Henglin Yang; Myaing M Nyunt; Matthew Adams; Shuisen Zhou; Zhigui Xia; Pascal Ringwald; Maria Dorina Bustos; Linhua Tang; Christopher V Plowe
Journal:  J Infect Dis       Date:  2015-04-24       Impact factor: 5.226

8.  Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali.

Authors:  Amed Ouattara; Aminatou Kone; Matthew Adams; Bakary Fofana; Amelia Walling Maiga; Shay Hampton; Drissa Coulibaly; Mahamadou A Thera; Nouhoum Diallo; Antoine Dara; Issaka Sagara; Jose Pedro Gil; Anders Bjorkman; Shannon Takala-Harrison; Ogobara K Doumbo; Christopher V Plowe; Abdoulaye A Djimde
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

9.  Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015.

Authors:  Costanza Tacoli; Prabhanjan P Gai; Claude Bayingana; Kevin Sifft; Dominik Geus; Jules Ndoli; Augustin Sendegeya; Jean Bosco Gahutu; Frank P Mockenhaupt
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

10.  Molecular Surveillance of Plasmodium falciparum Drug Resistance Markers in Clinical Samples from Botswana.

Authors:  Leabaneng Tawe; Michela Menegon; Pleasure Ramatlho; Charles W Muthoga; Naledi Mutukwa; Moses Vurayai; Wame Bothudile; Thato Motshoge; Mariangela L'Episcopia; Tjantilili Mosweunyane; Ishmael Kasvosve; Carlo Severini; Giacomo M Paganotti
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.